Cargando…
Higher expression of circulating miR-182 as a novel biomarker for breast cancer
MicroRNAs (miRNAs), present in the serum in a stable and reproducible manner, may be used as biomarkers for various diseases. Few studies have previously investigated circulating miRNAs in the peripheral blood of breast cancer (BC) patients. To identify the role of serum miR-182 levels in BC, the pr...
Autores principales: | WANG, PING-YU, GONG, HAI-TAO, LI, BAO-FENG, LV, CHUN-LEI, WANG, HUAN-TAI, ZHOU, HUI-HUI, LI, XIN-XIN, XIE, SHU-YANG, JIANG, BAO-FA |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3834356/ https://www.ncbi.nlm.nih.gov/pubmed/24260062 http://dx.doi.org/10.3892/ol.2013.1593 |
Ejemplares similares
-
Circulating miR-182 is a biomarker of colorectal adenocarcinoma progression
por: Perilli, Lisa, et al.
Publicado: (2014) -
Elevated circulating miR-182 acts as a diagnostic biomarker for early colorectal cancer
por: Liu, Xiangxiang, et al.
Publicado: (2018) -
Role of miR-182 in cardiovascular and cerebrovascular diseases
por: Pei, Gaiqin, et al.
Publicado: (2023) -
The Associations of Single Nucleotide Polymorphisms in miR-146a, miR-196a and miR-499 with Breast Cancer Susceptibility
por: Wang, Ping-Yu, et al.
Publicado: (2013) -
Exosomal miR-182 regulates the effect of RECK on gallbladder cancer
por: Zheng, Hong, et al.
Publicado: (2020)